denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Blood Journals Studio
Monday, December 11, 2023: 11:00 AM-12:00 PM
Halls G-H - Blood Journals Studio
(San Diego Convention Center)
Panelists:
Catherine M. Bollard, MD, Children's National Hospital and The George Washington University
and
Aaron T. Gerds, MD, MS, Cleveland Clinic
Disclosures:
Bollard: Cabaletta Bio, Catamaran Bio: Current equity holder in private company, Current equity holder in publicly-traded company, Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties: Patent applications in CAR-NKs; Roche: Consultancy. Gerds: AbbVie, Bristol Myers Squibb, Constellation Pharmaceuticals, GlaxoSmithKline, Kartos, Novartis, PharmaEssentia, Sierra Oncology: Consultancy; Accurate Pharmaceuticals, Constellation Pharmaceuticals, CTI BioPharma, Imago BioSciences, Incyte Corporation, Kratos Pharmaceuticals: Research Funding.
Dr. Aaron Gerds, Editor-in-Chief of ASH Clinical News, interviews Blood Advances Editor-in-Chief Dr. Catherine Bollard and Deputy Editor Andrew Weyrich on the topic of peer review.
See more of: Blood Journals Studio